Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Antihypertensive regimens that are lower cost when prescribed as a fixed-dose combination pill or free-equivalent products.


  1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303:2043–50.

    CAS  Article  Google Scholar 

  2. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. J Am Med Assoc. 2003;290:199–206.

    Article  Google Scholar 

  3. Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, et al. Trends in antihypertensive medication monotherapy and combination use among US adults, NHANES 2005-2016. Hypertension. 2020;75:973–81.

    CAS  Article  Google Scholar 

  4. Zhang Y, Moran AE. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70:736–42.

    CAS  Article  Google Scholar 

  5. Jaffe MG, Young JD. The Kaiser Permanente northern California story: improving hypertension control from 44% to 90% in 13 years (2000 to 2013). J Clin Hypertens. 2016;18:260–1.

    Article  Google Scholar 

  6. Fletcher RD, Amdur RL, Kolodner R, McManus C, Jones R, Faselis C, et al. Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the veterans administration health data repository. Circulation. 2012;125:2462–8.

    Article  Google Scholar 

  7. Du L-P, Cheng Z-W, Zhang Y-X, Li Y, Mei D. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. J Clin Hypertens. 2018;20:902–7.

    Article  Google Scholar 

  8. Mensah GA, Bakris G. Treatment and control of high blood pressure in adults. Cardiol Clin. 2010;28:609–22.

    Article  Google Scholar 

  9. Wright JT Jr., Williamson J, Whelton P, Snyder J, Sink K, Roccoo M, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.

    CAS  Article  Google Scholar 

  10. Paz MA, De-La-Sierra A, Sáez M, Barceló MA, Rodríguez JJ, Castro S, et al. Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement. Med. 2016;95:e4071.

    CAS  Article  Google Scholar 

  11. Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;2018:e127–e248.

    Google Scholar 

  12. Williams B, Mancia G, Spiering WI, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

    Article  Google Scholar 

  13. Ritchey M, Tsipas S, Loustalot F, Wozniak G. Use of pharmacy sales data to assess changes in prescription-and payment-related factors that promote adherence to medications commonly used to treat hypertension, 2009 and 2014. PLoS ONE. 2016;11:e0159366.

    Article  Google Scholar 

  14. Lauffenburger JC, Landon JE, Fischer MA. Effect of combination therapy on adherence among US patients initiating therapy for hypertension: a cohort study. J Gen Intern Med. 2017;32:619–25.

    Article  Google Scholar 

  15. Bennett A, Chow CK, Chou M, Dehbi HM, Webster R, Salam A, et al. Efficacy and safety of quarter-dose blood pressure-lowering agents: a systematic review and meta-analysis of randomized controlled trials. Hypertension. 2017;70:85–93.

    CAS  Article  Google Scholar 

  16. Webster R, Salam A, De Silva HA, Selak V, Stepien S, Rajapakse S, et al. Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka a randomized clinical trial. JAMA. 2018;320:566–79.

    CAS  Article  Google Scholar 

  17. Chow CK, Thakkar J, Bennett A, Hillis G, Burke M, Usherwood T, et al. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet. 2017;389:1035–42.

    CAS  Article  Google Scholar 

  18. Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A. Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: A systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37:1567–73.

    CAS  Article  Google Scholar 

  19. American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26–e50.

    Article  Google Scholar 

  20. Jamerson K, DeQuattro V. The impact of ethnicity on response to antihypertensive therapy. Am J Med. 1996;101:22S–32S.

    CAS  Article  Google Scholar 

  21. Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Arch Intern Med. 2000;160:825–31.

    CAS  Article  Google Scholar 

  22. Tocci G, Borghi C, Volpe M. Clinical management of patients with hypertension and high cardiovascular risk: Main results of an italian survey on blood pressure control. High Blood Press Cardiovasc Prev. 2014;21:107–17.

    Article  Google Scholar 

  23. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–64.

    Article  Google Scholar 

  24. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to or calcium channel blocker vs diuretic. JAMA. 2002;288:2981–97.

    Article  Google Scholar 

  25. Williams B, Macdonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386:2059–68.

    CAS  Article  Google Scholar 

Download references


APB is supported by K01HL133468 from the National Heart, Lung, and Blood Institute. CGD is supported by research funds received to her institution from Amgen, Inc. and Amarin Corporation for research unrelated to the current paper. JBC is supported by K23HL133843 from the National Heart, Lung, and Blood Institute.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Catherine G. Derington.

Ethics declarations

Conflict of interest

CGD is a past recipient of American Heart Association grant #19POST34380226/Derington/2019.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Derington, C.G., Cohen, J.B. & Bress, A.P. Restoring the upward trend in blood pressure control rates in the United States: a focus on fixed-dose combinations. J Hum Hypertens 34, 617–623 (2020).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links